• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Emeren Group Ltd filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

    11/4/24 4:10:18 PM ET
    $SOL
    Semiconductors
    Technology
    Get the next $SOL alert in real time by email
    false 0001417892 00-0000000 0001417892 2024-11-01 2024-11-01 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    WASHINGTON, D.C. 20549

     

     

     

    FORM 8-K

     

     

     

    CURRENT REPORT

     

    Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

     

    Date of Report (Date of earliest event reported): November 1, 2024

     

     

     

    EMEREN GROUP LTD

    (Exact name of Registrant as Specified in Its Charter)

     

     

     

    British Virgin Islands 001-33911 N/A

    (State or Other Jurisdiction

    of Incorporation)

    (Commission File Number)

    (IRS Employer

    Identification No.)

     

    149 Water Street, Suite 302

    Norwalk, Connecticut , U.S.A.

    06854
    (Address of Principal Executive Offices) (Zip Code)

     

    Registrant’s Telephone Number, Including Area Code: +1 925-425-7335

     

    (Former Name or Former Address, if Changed Since Last Report)

     

     

     

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

     

    ¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
       
    ¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
       
    ¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
       
    ¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

     

    Securities registered pursuant to Section 12(b) of the Act:

     

    Title of each class   Trading
    Symbol(s)
      Name of each exchange on which registered
    American depositary shares, each representing 10 shares, no par value per share   SOL   The New York Stock Exchange

     

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

     

    Emerging growth company ¨

     

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

      

     

     

     

     

    Item 5.07 Submission of Matters to a Vote of Security Holders.

     

    On November 1, 2024, Emeren Group Ltd (the “Company”) held its 2024 Annual Meeting of Shareholders (the “2024 Annual Meeting”). At the 2024 Annual Meeting, the Company’s shareholders voted on: (i) the appointment of Mr. Ramakrishnan Srinivasan as a director of the Company following his appointment as a director by the Board of Directors in accordance with the Company’s articles of association; (ii) the re-election of Martin Bloom and Yumin Liu, who are each offering himself for re-election, in accordance with the Company’s articles of association to hold office until a successor is duly elected and qualified; (iii) an advisory vote to approve the compensation of our named executive officers as disclosed in the Company’s definitive Proxy Statement, dated September 17, 2024, for the 2024 Annual Meeting (the “2024 Proxy Statement”); (iv) an advisory vote on the frequency of future advisory shareholder votes on the compensation of our named executive officers; and (v) ratification of the appointment of UHY LLP as our independent registered public accounting firm and auditors for 2024, as disclosed in the 2024 Proxy Statement.

     

    The appointment of Mr. Ramakrishnan Srinivasan as a director of the Company following his appointment as a director by the Board of Directors in accordance with the Company’s articles of association, was approved by the indicated votes cast:

     

    For   Against   Abstain   Broker Non-Votes 
     624,502,660    686,240    11,922,250    0 

     

    The re-elections of Martin Bloom and Yumin Liu, who each offered himself for re-election, in accordance with the Company’s articles of association to hold office until a successor is duly elected and qualified, were approved by the indicated votes cast:

     

    Name of Nominee  For   Against   Abstain   Broker Non-Votes 
    Mr. Martin Bloom   613,357,070    11,830,850    11,923,230    0 
    Mr. Yumin Liu   622,362,770    2,823,740    11,924,640    0 

     

    The advisory vote to approve the compensation of our named executive officers as disclosed in the accompanying proxy statement, was approved by the indicated votes cast:

     

    For   Against   Abstain   Broker Non-Votes 
     621,094,480    4,251,010    11,765,660    0 

     

    The advisory vote on the frequency of future advisory shareholder votes on the compensation of our named executive officers, was approved by the indicated votes cast:

     

    1 Year   2 Years   3 Years   Abstain   Broker Non-Votes 
     624,004,620    496,290    290,660    12,319,580    0 

     

    In accordance with the results for Proposal 4, the Company’s Board of Directors has determined that future advisory shareholder votes on the compensation of the Company’s named executive officers will be held annually. Thus, the next shareholder advisory vote on the compensation of our named executive officers will be held at the Company’s 2025 annual meeting of shareholders.

      

    The appointment of UHY LLP as our independent registered public accounting firm and auditors for 2024, as disclosed in the Company’s 2024 Proxy Statement, was ratified by the indicated votes cast:

     

    For   Against   Abstain  
     624,896,480    311,220    11,903,450  

     

    Further information concerning the matters voted upon at the 2024 Annual Meeting is contained in the 2024 Proxy Statement.

     

     

     

     

    SIGNATURES

     

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

     

      EMEREN GROUP LTD
      (Registrant)
         
    Date: November 4, 2024 By: /s/ Ke Chen
        Ke Chen
        Chief Financial Officer

     

     

     

    Get the next $SOL alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $SOL

    DatePrice TargetRatingAnalyst
    5/24/2024Market Perform → Under Perform
    Northland Capital
    11/22/2023$6.00 → $3.20Outperform → Market Perform
    Northland Capital
    9/13/2022$8.00Outperform
    Northland Capital
    1/5/2022$7.70 → $10.00Neutral → Buy
    ROTH Capital
    1/4/2022$12.50Outperform → Strong Buy
    Raymond James
    10/5/2021$14.50 → $12.50Outperform
    Raymond James
    9/1/2021$8.19 → $7.70Neutral
    Roth Capital
    More analyst ratings